GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kineta Inc (STU:J75) » Definitions » Machinery, Furniture, Equipment

Kineta (STU:J75) Machinery, Furniture, Equipment : €0.00 Mil (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Kineta Machinery, Furniture, Equipment?

Kineta's Machinery, Furniture, Equipment for the quarter that ended in Mar. 2024 was €0.00 Mil.

Kineta's quarterly Machinery, Furniture, Equipment declined from Sep. 2023 (€0.06 Mil) to Dec. 2023 (€0.00 Mil) but then stayed the same from Dec. 2023 (€0.00 Mil) to Mar. 2024 (€0.00 Mil).

Kineta's annual Machinery, Furniture, Equipment increased from Dec. 2021 (€0.06 Mil) to Dec. 2022 (€0.07 Mil) but then declined from Dec. 2022 (€0.07 Mil) to Dec. 2023 (€0.00 Mil).


Kineta Machinery, Furniture, Equipment Historical Data

The historical data trend for Kineta's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kineta Machinery, Furniture, Equipment Chart

Kineta Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Machinery, Furniture, Equipment
0.06 0.06 0.07 -

Kineta Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Machinery, Furniture, Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.06 0.06 - -

Kineta Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.


Kineta (STU:J75) Business Description

Industry
Traded in Other Exchanges
Address
219 Terry Avenue North, Suite 300, Seattle, WA, USA, 98109
Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.

Kineta (STU:J75) Headlines

No Headlines